Literature DB >> 9756207

Allergen challenge-induced extravasation of plasma in mouse airways.

J S Erjefält1, P Andersson, B Gustafsson, M Korsgren, B Sonmark, C G Persson.   

Abstract

BACKGROUND: Mouse models are extensively used to study genetic and immunological mechanisms of potential importance to inflammatory airway diseases, e.g. asthma. However, the airway pathophysiology in allergic mice has received less attention. For example, plasma extravasation and the ensuing tissue-deposition of plasma proteins, which is a hallmark of inflammation, has not been examined in allergic mice.
OBJECTIVE: This study aims to examine the vascular permeability and the distribution of plasma proteins in mouse airways following exposure to allergen and serotonin.
METHODS: Extravasated plasma was quantified by a dual isotop technique using intravascular (131I-albumin) and extrasvascular (125I-albumin) plasma tracers. Histological visualization of fibrinogen and colloidal gold revealed the tissue distribution of extravasated plasma.
RESULTS: Allergen aerosol exposure (3% OVA, 15min) of sensitized animals resulted in a marked plasma extravasation response in the trachea (P < 0.01) and the bronchi but not in the lung parenchyma. A similar extravasation response was induced by serotonin (P<0.001). Extravasating vessels (assessed by Monastral blue dye) were identified as intercartilaginous venules. Extravasated plasma abounded in the subepithelial tissue but was absent in the epithelium and airway lumen. The allergen-induced response was dose-dependently inhibited by iv administration of formoterol (P < 0.001), a vascular antipermeability agent.
CONCLUSION: The present study demonstrates that serotonin and allergen challenge of sensitized mice increase airway venular permeability to cause transient extravasation and lamina propria distribution of plasma in the large airways. We suggest that the extravasation response is a useful measure of the intensity and the distribution of active inflammation

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9756207     DOI: 10.1046/j.1365-2222.1998.00372.x

Source DB:  PubMed          Journal:  Clin Exp Allergy        ISSN: 0954-7894            Impact factor:   5.018


  7 in total

Review 1.  Humoral First-Line Mucosal Innate Defence in vivo.

Authors:  Carl Persson
Journal:  J Innate Immun       Date:  2020-03-23       Impact factor: 7.349

2.  Murine model for non-IgE-mediated asthma.

Authors:  Hanneke P M van der Kleij; Aletta D Kraneveld; Anneke H van Houwelingen; Mirjam Kool; Andrys C D Weitenberg; Frank A M Redegeld; Frans P Nijkamp
Journal:  Inflammation       Date:  2004-06       Impact factor: 4.092

3.  Synergistic effect of formoterol and mometasone in a mouse model of allergic lung inflammation.

Authors:  D Wyss; O Bonneau; A Trifilieff
Journal:  Br J Pharmacol       Date:  2007-07-09       Impact factor: 8.739

4.  The Temporal Evolution of Airways Hyperresponsiveness and Inflammation.

Authors:  Erik Riesenfeld; Gilman B Allen; Jason Ht Bates; Matthew E Poynter; Min Wu; Steven Aimiand; Lennart Ka Lundblad
Journal:  J Allergy Ther       Date:  2012-01-25

5.  Detrimental effects of albuterol on airway responsiveness requires airway inflammation and is independent of β-receptor affinity in murine models of asthma.

Authors:  Lennart K A Lundblad; Lisa M Rinaldi; Matthew E Poynter; Erik P Riesenfeld; Min Wu; Steven Aimi; Leesa M Barone; Jason H T Bates; Charles G Irvin
Journal:  Respir Res       Date:  2011-03-07

6.  Fluticasone Induces Epithelial Injury and Alters Barrier Function in Normal Subjects.

Authors:  Ruth E MacRedmond; Gurpreet K Singhera; Samuel J Wadsworth; Susan Attridge; Mohammed Bahzad; Kristy Williams; Harvey O Coxson; Steven R White; Delbert R Dorscheid
Journal:  J Steroids Horm Sci       Date:  2014-06-11

Review 7.  Early humoral defence: Contributing to confining COVID-19 to conducting airways?

Authors:  Carl Persson
Journal:  Scand J Immunol       Date:  2021-02-07       Impact factor: 3.889

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.